losartan has been researched along with Chronic Pancreatitis in 4 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fibrosis was accompanied by activation of pancreatic stellate cells (PSC) evaluated by Western blot analysis for alpha-smooth muscle actin." | 5.36 | Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse. ( Neuschwander-Tetri, BA; Oshima, K; Talkad, V; Ulmasov, B; Xu, Z, 2010) |
| "Fibrosis was accompanied by activation of pancreatic stellate cells (PSC) evaluated by Western blot analysis for alpha-smooth muscle actin." | 1.36 | Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse. ( Neuschwander-Tetri, BA; Oshima, K; Talkad, V; Ulmasov, B; Xu, Z, 2010) |
| " Corresponding dosage of Losartan can also alleviate the motion capability and type I collagen content of hPSCs compared with AngII treatment and non-treatment control groups." | 1.33 | Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells. ( Liu, WB; Wang, XP; Wu, K; Zhang, RL, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madro, A | 2 |
| Kurzepa, J | 2 |
| Celinski, K | 2 |
| Slomka, M | 1 |
| Czechowska, G | 2 |
| Kazmierak, W | 1 |
| Buszewicz, G | 1 |
| Ciesielka, M | 1 |
| Madro, R | 1 |
| Korolczuk, A | 1 |
| Słomka, M | 1 |
| Prozorow-Król, B | 1 |
| Korobowicz, E | 1 |
| Ulmasov, B | 1 |
| Xu, Z | 1 |
| Talkad, V | 1 |
| Oshima, K | 1 |
| Neuschwander-Tetri, BA | 1 |
| Liu, WB | 1 |
| Wang, XP | 1 |
| Wu, K | 1 |
| Zhang, RL | 1 |
4 other studies available for losartan and Chronic Pancreatitis
| Article | Year |
|---|---|
Effects of renin-angiotensin system inhibitors on fibrosis in patients with alcoholic chronic pancreatitis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Female; Humans; Liver Cirrhosis; Losart | 2016 |
RAS inhibitors decrease apoptosis of acinar cells and increase elimination of pancreatic stellate cells after in the course of experimental chronic pancreatitis induced by dibutyltin dichloride.
Topics: Actins; Aldosterone; Animals; Apoptosis; Captopril; Cell Proliferation; Enalapril; Immunohistochemis | 2008 |
Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse.
Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrophy; Ceruletide; Colla | 2010 |
Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Apoptosis; Cell Division; Cell Movement; Cells, Cultured; F | 2005 |